Search results for "cut"

showing 10 items of 5063 documents

The Performative University: ‘Targets’, ‘Terror’ and ‘Taking Back Freedom’ in Academia

2020

The file attached to this record is the author's final peer reviewed version. The Publisher's final version can be found by following the DOI link. This special issue assembles eight papers which provide insights into the working lives of early career to more senior academics, from several different countries. The first common theme which emerges is around the predominance of ‘targets’, enacting aspects of quantification and the ideal of perfect control and fabrication. The second theme is about the ensuing precarious evocation of ‘terror’ impacting on mental well-being, albeit enacted in diverse ways. Furthermore, several papers highlight a particular type of response, beyond complicity to…

2019-20 coronavirus outbreakAlternative organizationsUniversitiesHigher educationbusiness.industryStrategy and ManagementSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Critical management studiesGeneral Decision SciencesGender studiesPerformative utteranceCritical management studiesperformativityManagement of Technology and InnovationPerformativityHigher educationSociologyEarly careerBusiness schoolsbusinessInstitute for Management ResearchTheme (narrative)Management Learning
researchProduct

Anakinra for severe forms of COVID-19

2020

2019-20 coronavirus outbreakAnakinraRheumatologyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyImmunology and AllergyMedicinebusinessVirologyArticlemedicine.drugThe Lancet Rheumatology
researchProduct

An expression of concern on research during the Covid-19 pandemic

2020

2019-20 coronavirus outbreakBiomedical ResearchCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralScientific MisconductSettore MED/11BetacoronavirusRetraction of Publication as TopicPandemicHumansMedicinePandemicsClinical Trials as TopicbiologySARS-CoV-2business.industryCOVID-19Reproducibility of ResultsGeneral Medicinebiology.organism_classificationVirologyCoronavirus InfectionsCardiology and Cardiovascular MedicinebusinessBetacoronavirusCoronavirus Infections
researchProduct

2020

In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+ households compared to those with owners of unknown status. Our results highlight the potential role of pets in the spread of the epidemic.

2019-20 coronavirus outbreakCATSHigh prevalenceCoronavirus disease 2019 (COVID-19)biologybusiness.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030231 tropical medicinePublic Health Environmental and Occupational HealthVirology3. Good health03 medical and health sciences0302 clinical medicineInfectious DiseasesOne Healthbiology.proteinMedicineSeroprevalence030212 general & internal medicineAntibodybusinessOne Health
researchProduct

Towards a European strategy to address the COVID-19 pandemic

2021

2019-20 coronavirus outbreakCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Physical DistancingMass Vaccination03 medical and health sciences0302 clinical medicinePolitical scienceCorrespondencePandemicHumans030212 general & internal medicinePandemicsHealth policy030304 developmental biology0303 health sciencesSARS-CoV-2Health PolicyIncidenceIncidence (epidemiology)COVID-19General MedicineVirology3. Good healthEuropeMass vaccinationHuman medicineThe Lancet
researchProduct

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults

2022

International audience; Safe and effective vaccines against coronavirus disease 2019 (COVID-19) are essential for ending the ongoing pandemic. Although impressive progress has been made with several COVID-19 vaccines already approved, it is clear that those developed so far cannot meet the global vaccine demand alone. We describe a COVID-19 vaccine based on a replication-defective gorilla adenovirus expressing the stabilized prefusion severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein named GRAd-COV2. We assessed the safety and immunogenicity of a single-dose regimen of this vaccine in healthy younger and older adults to select the appropriate dose for each age group…

2019-20 coronavirus outbreakCOVID-19 VaccinesSettore BIO/06Coronavirus disease 2019 (COVID-19)COVID-19 VaccineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)GorillaAdenoviridaeAdenovirus Vaccinesbiology.animalPandemicAnimalsHumansMedicineMESH: COVID-19MESH: AnimalsMESH: SARS-CoV-2AgedMESH: Adenovirus VaccinesMESH: AgedGorilla gorilla[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyMESH: HumansbiologyAnimalSARS-CoV-2business.industryMESH: Gorilla gorillaCOVID-19MESH: AdenoviridaeGeneral MedicineVirologyAdenovirus VaccineMESH: COVID-19 Vaccinesbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyHuman
researchProduct

How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN…

2020

Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems worldwide. Patients with malignant diseases are assumed to be at increased risk for a worse outcome of SARS-CoV-2 infection, and therefore, guidance regarding prevention and management of the infection as well as safe administration of cancer-therapy is required. Here, we provide recommendations for the management of patients with malignant disease in the times of COVID-19. These recommendations were prepared by an international panel of experts and then consented by the EHA Scientific Working Group on Infection in Hematology. The primary aim is to enable clinicians to provide optimal cancer care as safely…

2019-20 coronavirus outbreakCancer ResearchPneumonia ViralDiseasesSevere Acute Respiratory Syndromemedicine.disease_causeBetacoronavirusMyeloproliferative DisordersNeoplasmsSurveys and QuestionnairesPandemicmedicineHumansPandemicsCoronavirusPhiladelphia negativeMyeloproliferative DisordersbiologySARS-CoV-2business.industryHealth careCOVID-19Hematologymedicine.diseasebiology.organism_classificationVirologyCoronavirusPneumoniaItalyOncologyPerspectiveCoronavirus InfectionsbusinessCoronavirus InfectionsBetacoronavirusBetacoronavirus COVID-19 Humans Italy SARS-CoV-2 Surveys and Questionnaires Coronavirus Coronavirus Infections Myeloproliferative Disorders Neoplasms Pandemics Pneumonia Viral Severe Acute Respiratory Syndrome
researchProduct

COVID-19 and economy.

2020

2019-20 coronavirus outbreakChinaLetterCoronavirus disease 2019 (COVID-19)business.industryViral EpidemiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINECOVID-19DermatologyGeneral Medicinemedicine.diseaseGlobal HealthVirologyPneumoniaMedicineHumansLettersbusinessCoronavirus InfectionsPandemicsDermatologic therapy
researchProduct

Testing & Opening in Augustusburg A Success Story?

2021

AbstractThe city of Augustusburg allowed for opening of, inter alia, restaurants and hotels joint with large-scale testing. We evaluate this testing & opening (T&O) experiment by comparing the evolution of case rates in Augustusburg with the evolution in other communities of Saxony. We have access to small-scale SARS-CoV-2 infection data at the community level (” Gemeinde”) instead of the county level (” Landkreis”) usually used for disease surveillance. Despite data challenges, we conclude that T&O did not lead to any increase in case rates in Augustusburg compared to its control county. When we measure the effect of T&O on cumulative cases, we find a small increase in Augu…

2019-20 coronavirus outbreakCommunity levelGeographyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)County levelDemography
researchProduct

Mpro-SARS-CoV-2 Inhibitors and Various Chemical Reactivity of 1-Bromo- and 1-Chloro-4-vinylbenzene in [3 + 2] Cycloaddition Reactions

2021

The regioselectvity and the mechanism of the (32CA) cycloadditions reactions of 1-bromo-4-vinylbenzene 1 and 1-chloro-4-vinylbenzene 2 with benzonitrile oxide 3 were investigated under the molecular electron density theory (MEDT) at the B3LYP/6-311++G(d,p) computational level. Evaluation of the ELF reveals that these zwitterionic type (zw-type) 32CA reactions take place in a two-stage one-step mechanism. This MEDT study shows that the meta isoxazolines are kinetically and thermodynamically favored over the ortho ones, these 32CA reactions being completely regioselective, in agreement with experimental outcomes. In addition, the efficiency of isoxazolines against SARS-CoV-2 have been also in…

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)010405 organic chemistryChemistrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)OxideMEDTRegioselectivity010402 general chemistry01 natural sciencesMedicinal chemistryDFTCycloaddition3. Good health0104 chemical scienceschemistry.chemical_compoundBenzonitrileELFDocking (molecular)regioselectivity2-isoxazolineOrganics
researchProduct